On October 24, 2023, the company has issued 42 units at an issue price of $25,000 for gross proceeds of $1,050,000 in its third tranche closing. In this connection, the company paid a placement agent fees of $157,500.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 USD | +2.94% | +6.60% | +9.66% |
1st Jan change | Capi. | |
---|---|---|
+9.66% | 16.79M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- OTLC Stock
- News Oncotelic Therapeutics, Inc.
- Oncotelic Therapeutics, Inc. announces tranche update